Protocol·One

PT-141 · For low libido

PT-141 for low libido

You're in your 40s and libido is gone. PT-141 / bremelanotide?

A-Tier Sexual Health FDA-approved

Why people use PT-141 for low libido

You're in your 40s and libido is gone. PT-141 / bremelanotide? The honest answer: yes, and it clears the highest bar - it is FDA-approved for this. FDA-approved as Vyleesi for premenopausal women with HSDD (hypoactive sexual desire disorder).

This page covers what's known, what's not, and what the editorial take is for normal humans considering PT-141 for low libido.

What the evidence says

Evidence tier: FDA-approved. FDA-approved with multiple randomized trials behind it. The strongest evidence tier in this matrix.

  • FDA-approved as Vyleesi for premenopausal women with HSDD (hypoactive sexual desire disorder).
  • Off-label use spans men and post-menopausal women.
  • Acts on melanocortin receptors in the brain, not on circulation.

Protocol notes

0.75mg-1.75mg subcutaneous, used as-needed (2-8 hours before activity). Not daily.

Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.

What to skip

  • Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
  • Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
  • Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.

Where to go next

New to peptides? Start with the foundations ->

Your next step

See the full PT-141 dosing protocol Find your fit · 2-min quiz